Paper3976802
Natural course of retinitis pigmentosa over a three-year interval.
Berson EL and 4 others. Am J Ophthalmol, 1985. Cited by 271 papers, by iCite.
Cite this record
ConductScience Library. Natural course of retinitis pigmentosa over a three-year interval. Papers, record 3976802. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3976802
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Retinitis Pigmentosa | Major topic |
| Vision, Ocular | Major topic |
| Adolescent | |
| Adult | |
| Child | |
| Dark Adaptation | |
| Electroretinography | |
| Female | |
| Fluorescein Angiography | |
| Humans | |
| Male | |
| Middle Aged | |
| Time Factors | |
| Visual Acuity | |
| Visual Fields |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| EY02014 | NEI NIH HHS | United States | U01EY002014 | PubMed and NIH | NIH RePORTER |
| U10EY002014 | NIH | NIH RePORTER |
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT01233609 | Trial of Oral Valproic Acid for Retinitis Pigmentosa | Background |
Source ClinicalTrials.gov
Cited by114
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 271 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42787486 | A 48-Month, Prospective, Multicenter, Natural History Study of Choroideremia. | Ophthalmol Sci | 2026 | https://conductscience.org/library/papers/42787486 | PubMed |
| 42668498 | Characterizing the non-pigmented retinitis pigmentosa in a Chinese cohort: Insights into phenotype, genotype, and disease progression. | Adv Ophthalmol Pract Res | 2026 | https://conductscience.org/library/papers/42668498 | PubMed |
| 42137601 | Single-cell and spatial transcriptomic analyses of gene therapy-associated retinal inflammation in non-human primates. | Mol Ther Adv | 2026 | https://conductscience.org/library/papers/42137601 | PubMed |
| 40261664 | PCARE-Associated Retinopathy - Genetics, Clinical Characteristics, and Natural History. | Invest Ophthalmol Vis Sci | 2025 | https://conductscience.org/library/papers/40261664 | PubMed |
| 39811267 | Longitudinal Assessment of Structural and Functional Changes in Rod-cone Dystrophy: A 10-year Follow-up Study. | Ophthalmol Sci | 2025 | https://conductscience.org/library/papers/39811267 | PubMed |
| 39627217 | Efficacy and safety of minocycline in retinitis pigmentosa: a prospective, open-label, single-arm trial. | Signal Transduct Target Ther | 2024 | https://conductscience.org/library/papers/39627217 | PubMed |
| 38140908 | Intraflagellar transport: A critical player in photoreceptor development and the pathogenesis of retinal degenerative diseases. | Cytoskeleton (Hoboken) | 2024 | https://conductscience.org/library/papers/38140908 | PubMed |
| 38133503 | Treatment Strategy With Gene Editing for Late-Onset Retinal Degeneration Caused by a Founder Variant in C1QTNF5. | Invest Ophthalmol Vis Sci | 2023 | https://conductscience.org/library/papers/38133503 | PubMed |
| 37713598 | Management of Retinitis Pigmentosa Via Wharton's Jelly-Derived Mesenchymal Stem Cells or Combination With Magnovision: 3-Year Prospective Results. | Stem Cells Transl Med | 2023 | https://conductscience.org/library/papers/37713598 | PubMed |
| 37696658 | Current Status of Clinical Trials Design and Outcomes in Retinal Gene Therapy. | Cold Spring Harb Perspect Med | 2024 | https://conductscience.org/library/papers/37696658 | PubMed |
| 37676679 | Spatial Cluster Patterns of Retinal Sensitivity Loss in Intermediate Age-Related Macular Degeneration Features. | Transl Vis Sci Technol | 2023 | https://conductscience.org/library/papers/37676679 | PubMed |
| 37525225 | A multidisciplinary approach to inherited retinal dystrophies from diagnosis to initial care: a narrative review with inputs from clinical practice. | Orphanet J Rare Dis | 2023 | https://conductscience.org/library/papers/37525225 | PubMed |
| 37261916 | Natural history of retinitis pigmentosa based on genotype, vitamin A/E supplementation, and an electroretinogram biomarker. | JCI Insight | 2023 | https://conductscience.org/library/papers/37261916 | PubMed |
| 37123408 | The double-edged sword of inflammation in inherited retinal degenerations: Clinical and preclinical evidence for mechanistically and prognostically impactful but treatable complications. | Front Cell Dev Biol | 2023 | https://conductscience.org/library/papers/37123408 | PubMed |
| 37113027 | New insights in the multimodal imaging of retinitis pigmentosa. | Eur J Ophthalmol | 2024 | https://conductscience.org/library/papers/37113027 | PubMed |
| 37108642 | Retinitis Pigmentosa: Current Clinical Management and Emerging Therapies. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37108642 | PubMed |
| 37009075 | Anxiety and Depression in Patients With Retinitis Pigmentosa. | J Vitreoretin Dis | 2021 | https://conductscience.org/library/papers/37009075 | PubMed |
| 36840007 | Retinitis Pigmentosa: Novel Therapeutic Targets and Drug Development. | Pharmaceutics | 2023 | https://conductscience.org/library/papers/36840007 | PubMed |
| 36690461 | The Importance of Natural History Studies in Inherited Retinal Diseases. | Cold Spring Harb Perspect Med | 2023 | https://conductscience.org/library/papers/36690461 | PubMed |
| 36498452 | A Natural History Study of RP2-Related Retinopathy. | J Clin Med | 2022 | https://conductscience.org/library/papers/36498452 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3976802
GET https://conductscience.org/api/papers/v1/3976802/cited_by?page=2